Rx News
Possible Suboxone Alternatives
March 5, 2013
There have been a number of events over the past couple weeks that have been 'game changers' in the efforts by Reckitt Benckiser to hang onto their profitable treatment for opioid dependence, Suboxone. Reckitt Benckiser asked the FDA to deny any future generic drugs based on Suboxone tabs because of deaths of several chldren, who might have confused the tabs for candy.
The FDA considered Reckitt Benckiser's comments but discarded them, stating that the efforts by Reckitt Benckiser may have been unlawful anticompetetive marketing. The FDA wrote that they were referring their concerns about unlawful marketing to the FTC.
The FDA approved two generic versions of Suboxone. Then the FDA announced that they will be holding hearings to determine whether to approve a buprenorphine implant called Probuphine. The manufacturers of Probuphine are hoping that the medication will be used to treat opioid dependence. Not mentioned at this point, is whether the implant could help people who would like to discontinue Suboxone. Many patients on Suboxone become resentful of the medication at some point, wishing they could be completely free from opioids.
News Topics
Top News Articles
- New Parkinson's Disease Drug Approved
May 4, 2017 - Hypertension Guidelines Consensus Statement
April 1, 2017 - Novel Abuse-Deterrent Morphine Approved
March 1, 2017 - New Heart Failure Guidelines
February 1, 2017 - New Eczema Drug Approved
January 1, 2017